Amgen 2009 Annual Report Download - page 51

Download and view the complete annual report

Please find page 51 of the 2009 Amgen annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 180

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • 164
  • 165
  • 166
  • 167
  • 168
  • 169
  • 170
  • 171
  • 172
  • 173
  • 174
  • 175
  • 176
  • 177
  • 178
  • 179
  • 180

Communications Corporation (“MCI”). From February 1984 to March 1989, Mr. Sharer held numerous execu-
tive capacities at General Electric Company (“GE”). Mr. Sharer is a director of Chevron Corporation and
Northrop Grumman Corporation. He is a trustee of the California Institute of Technology, or Caltech.
Mr. David W. Beier, age 61, became Senior Vice President, Global Government and Corporate Affairs in
March 2008. He joined the Company in 2003 as Senior Vice President, Global Government Affairs. Previously,
Mr. Beier was a partner with the law firm of Hogan and Hartson in Washington, D.C. From 1998 to early 2001,
Mr. Beier served as Chief Domestic Policy Advisor to the Vice President of the United States. He also held posi-
tions as Vice President of Government Affairs and Public Policy for Genentech and staff counsel in the U.S.
House of Representatives. Mr. Beier is a director of ARYx Therapeutics, Inc.
Dr. Fabrizio Bonanni, age 63, became Executive Vice President, Operations in August 2007. He has served
as Senior Vice President, Manufacturing of the Company since 2004. Dr. Bonanni joined the Company in 1999
as Senior Vice President, Quality and Compliance and in June 2001 he also became the Corporate Compliance
Officer. Previously, Dr. Bonanni held various management positions at Baxter International, Inc. from 1974 to
1999, including positions as Corporate Vice President, Regulatory and Clinical Affairs and Corporate Vice
President, Quality System.
Mr. Robert A. Bradway, age 47, became Executive Vice President and Chief Financial Officer in April
2007. He joined the Company in 2006 as Vice President, Operations Strategy. Previously, Mr. Bradway had an
18 year career at Morgan Stanley in New York and London where he was a managing director in investment
banking. Mr. Bradway led Morgan Stanley’s healthcare practice in Europe for several years and also ran Morgan
Stanley’s European banking department.
Mr. Thomas J. Flanagan, age 60, became Senior Vice President and Chief Information Officer in October
2006. From June 2004 to October 2006, Mr. Flanagan served as Vice President, Information Systems. From De-
cember 1995 to May 2004, Mr. Flanagan served in a variety of executive positions including Chief Information
Officer and Vice President, Global Service Delivery at MCI.
Mr. Brian McNamee, age 53, became Senior Vice President, Human Resources in June 2001. From No-
vember 1999 to June 2001, Mr. McNamee served as Vice President of Human Resources at Dell Computer Corp.
From 1998 to 1999, Mr. McNamee served as Senior Vice President, Human Resources for the National Broad-
casting Corporation, a division of GE. From July 1988 to November 1999, Mr. McNamee held human resource
positions at GE.
Mr. George J. Morrow, age 57, became Executive Vice President of Worldwide Sales and Marketing in Jan-
uary 2001 and became Executive Vice President, Global Commercial Operations in April 2003. From January
1999 to December 2000, Mr. Morrow was President and Chief Executive Officer of Glaxo Wellcome Inc.
(“Glaxo”), a subsidiary of GlaxoSmithKline. From January 1997 to December 1998, Mr. Morrow was Managing
Director of Glaxo Wellcome U.K., also a subsidiary of GlaxoSmithKline. From May 1993 to December 1996,
Mr. Morrow was Group Vice President for Commercial Operations of Glaxo. Mr. Morrow currently serves on
the Board of Directors of Align Technology, Inc.
Dr. Roger M. Perlmutter, age 57, became Executive Vice President, Research and Development in January
2001. From July 1999 to December 2000, Dr. Perlmutter was Executive Vice President, Worldwide Basic Re-
search and Preclinical Development of Merck Research Laboratories. From February 1999 to July 1999,
Dr. Perlmutter served as Executive Vice President of Merck Research Laboratories, and from February 1997 to
January 1999, as Senior Vice President of Merck Research Laboratories. From May 1989 to January 1997,
Dr. Perlmutter was also Chairman of the Department of Immunology, University of Washington, and from Jan-
uary 1991 to January 1997, Professor in the Departments of Immunology, Biochemistry and Medicine,
University of Washington. From July 1984 to January 1997, Dr. Perlmutter served as Investigator at the Howard
Hughes Medical Institute at the University of Washington. Dr. Perlmutter currently serves on the Board of Direc-
tors of StemCells, Inc.
Ms. Anna S. Richo, age 49, became Senior Vice President and Chief Compliance Officer in June 2008.
From December 2003 to June 2008, Ms. Richo served as Vice President, Law. Prior to Amgen, she spent 12
39